Shutterstock
Dalip Sethi, Ph.D., Commercial Leader, Cell Therapy Technologies and Joy Duemke, Director of Marketing, North America, at Terumo Blood and Cell Technologies.
Automated Apheresis Platforms Function as a Therapeutic and an Enabling Technology for Cell-Based Therapies
Dalip Sethi, Ph.D. and Joy Duemke, at Terumo Blood and Cell Technologies explore how automated apheresis platforms function as a therapeutic and an enabling technology for cell-based therapies.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.